Sorbent Therapeutics develops fluid-retaining polymers for kidney disease therapeutics.
Sorbent Therapeutics, Inc. develops treatment for end stage renal disease patients undergoing dialysis. The company develops fluid retaining polymers for therapeutic uses, such as treatment of kidney diseases. Sorbent Therapeutics, Inc. was founded in 2005 and is based in Vernon Hills, Illinois.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 15, 2014 | Series D | $6.50M | 2 | — | — | Detail |
Apr 1, 2013 | Series Unknown | $2.53M | 1 | — | — | Detail |
Aug 8, 2012 | Series C | $18.05M | 1 | — | — | Detail |
Jun 30, 2011 | Series B | $36M | 2 | — | — | Detail |
Sep 13, 2010 | Series B | $21.80M | 2 | AgeChem Venture Fund | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
ARCH Venture Partners | — | Series D |
AgeChem Venture Fund | — | Series D |